Associate Professor Kerrie McDonald is the Chief Executive Officer of the Australian Not-For-Profit Charity, Cure Brain Cancer Foundation (CBCF). A/Prof McDonald has dedicated most of her working life as an academic researcher to finding better treatment options for people impacted by brain cancer. For over 15 years, she led a large translational biomarker and drug discovery group. Her work at the bench resulted in two Phase 1 trials and two Phase 2 trials for patients with newly diagnosed and recurrent glioblastoma.
A/Prof McDonald is passionate about creating improvements in the management of brain cancer patients and is a strong advocate for collaboration, both in the clinical setting and research. In 2019, she made the switch from Academia to the Charity sector and took up the role of CEO of CBCF in July 2019. CBCF is the leading organisation for brain cancer research, awareness and advocacy in Australia. The mission is bold: to increase five-year survival from the current 20% to 50% by 2023. Partnering with the research community, CBCF is steering the national agenda and influencing the global agenda for brain cancer research.